Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SmithKline Beecham patents combined 5-HT1A/5-HT1B/5-HT1D receptor antagonists

Dec. 22, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

First evidence that citicoline favorably affects human brain lipid metabolism

Dec. 21, 1998

EP1 receptor antagonists described by Ono for pain, fever and diuresis

Dec. 21, 1998

Allelix treatment for dementia enters phase I trials

Dec. 21, 1998

FDA approves Treatment IND for Orphan Medical's Xyrem oral solution

Dec. 21, 1998

U.K. launch for novel antipsychotic agent: zotepine

Dec. 18, 1998

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Lilly patents novel mGluR modulators

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...